Naproxennatrium Liquid Caps Kruidvat (Naproxen Sodium)

Naproxen sodium works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish inflammation, pain signaling, and fever, providing therapeutic relief in conditions where these mediators are elevated.

The specific dose of Naproxennatrium Liquid Caps is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, renal function and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of naproxen sodium in pregnancy or lactation has not been definitively established. It is generally avoided in the third trimester because of potential fetal cardiovascular effects, and caution is advised during breastfeeding. Healthcare providers should evaluate risks versus benefits before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen and ibuprofen are NSAIDs that inhibit COX enzymes, but naproxen has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a slightly faster onset. Their safety profiles are similar, though naproxen may carry a marginally higher risk of gastrointestinal irritation in long‑term use.

Naproxennatrium Liquid Caps should be stored at ambient temperature, preferably below 25 °C. Keep the capsules in the original packaging, protect them from moisture, direct sunlight and excessive heat to maintain product stability throughout its shelf life.

The capsules are intended for oral administration. They should be swallowed whole with a full glass of water, preferably with food or milk to reduce gastrointestinal discomfort, unless the prescriber provides alternative instructions.

Serious risks include gastrointestinal bleeding or ulcer perforation, severe renal impairment, cardiovascular events such as myocardial infarction or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as black stools, sudden kidney problems, chest pain, or severe rash.

Naproxen sodium is contraindicated in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, and those who have had a recent coronary artery bypass graft. It should also be used with caution in patients with asthma, renal or hepatic impairment.